QS Investors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $6.78M | Buy |
17,743
+9,139
| +106% | +$3.49M | 0.08% | 185 |
|
|
2021
Q1 | $3.09M | Sell |
8,604
-587
| -6% | -$189K | 0.04% | 304 |
|
|
2020
Q4 | $2.95M | Buy |
9,191
+332
| +4% | +$102K | 0.04% | 302 |
|
|
2020
Q3 | $2.38M | Sell |
8,859
-1,030
| -10% | -$277K | 0.03% | 302 |
|
|
2020
Q2 | $2.6M | Sell |
9,889
-586
| -6% | -$156K | 0.04% | 391 |
|
|
2020
Q1 | $2.38M | Sell |
10,475
-2,132
| -17% | -$581K | 0.04% | 358 |
|
|
2019
Q4 | $3.79M | Sell |
12,607
-599
| -5% | -$165K | 0.04% | 363 |
|
|
2019
Q3 | $3.17M | Sell |
13,206
-300
| -2% | -$82.2K | 0.03% | 405 |
|
|
2019
Q2 | $3.81M | Sell |
13,506
-700
| -5% | -$191K | 0.04% | 353 |
|
|
2019
Q1 | $4.08M | Sell |
14,206
-496
| -3% | -$143K | 0.04% | 332 |
|
|
2018
Q4 | $3.86M | Sell |
14,702
-7,511
| -34% | -$2.07M | 0.05% | 293 |
|
|
2018
Q3 | $6.09M | Sell |
22,213
-1,360
| -6% | -$353K | 0.06% | 222 |
|
|
2018
Q2 | $5.61M | Sell |
23,573
-1,502
| -6% | -$348K | 0.06% | 249 |
|
|
2018
Q1 | $5.51M | Sell |
25,075
-219
| -0.9% | -$51.4K | 0.06% | 227 |
|
|
2017
Q4 | $5.69M | Sell |
25,294
-4,710
| -16% | -$1M | 0.05% | 257 |
|
|
2017
Q3 | $5.7M | Buy |
30,004
+8,089
| +37% | +$1.54M | 0.05% | 257 |
|
|
2017
Q2 | $4.12M | Buy |
21,915
+1,818
| +9% | +$327K | 0.04% | 369 |
|
|
2017
Q1 | $3.32M | Sell |
20,097
-51,769
| -72% | -$8.24M | 0.03% | 440 |
|
|
2016
Q4 | $10.3M | Sell |
71,866
-21,029
| -23% | -$2.82M | 0.08% | 176 |
|
|
2016
Q3 | $11.6M | Buy |
92,895
+46,771
| +101% | +$6.04M | 0.09% | 177 |
|
|
2016
Q2 | $6.06M | Buy |
46,124
+23,085
| +100% | +$3.16M | 0.05% | 324 |
|
|
2016
Q1 | $3.2M | Buy |
23,039
+43
| +0.2% | +$5.75K | 0.03% | 522 |
|
|
2015
Q4 | $3.21M | Sell |
22,996
-102,066
| -82% | -$14.1M | 0.03% | 536 |
|
|
2015
Q3 | $17.5M | Sell |
125,062
-57,328
| -31% | -$8.62M | 0.18% | 104 |
|
|
2015
Q2 | $29.9M | Sell |
182,390
-16,853
| -8% | -$2.69M | 0.37% | 52 |
|
|
2015
Q1 | $30.8M | Sell |
199,243
-28,226
| -12% | -$4.02M | 0.35% | 58 |
|
|
2014
Q4 | $28.6M | Buy |
227,469
+19,888
| +10% | +$2.46M | 0.33% | 62 |
|
|
2014
Q3 | $24.8M | Buy |
207,581
+169,330
| +443% | +$19.4M | 0.67% | 37 |
|
|
2014
Q2 | $4.12M | Sell |
38,251
-8,415
| -18% | -$867K | 0.11% | 176 |
|
|
2014
Q1 | $4.65M | Sell |
46,666
-146,700
| -76% | -$13.3M | 0.14% | 161 |
|
|
2013
Q4 | $17.9M | Sell |
193,366
-2,250
| -1% | -$200K | 0.68% | 32 |
|
|
2013
Q3 | $16.4M | Sell |
195,616
-141,834
| -42% | -$12.2M | 0.71% | 34 |
|
|
2013
Q2 | $27.6M | Buy |
+337,450
| New | +$25.3M | 0.97% | 10 |
|
Other funds holding ELV
QS Investors's ELV Position: Q2 2021 in Review
QS Investors increased its Elevance Health (ELV) stake by 106% in Q2 2021, buying an estimated $3.49M and bringing the position to 17,743 shares worth $6.78M. The position accounts for 0.08% of the portfolio, ranked #185.
QS Investors first reported a position in ELV in Q2 2013 and has held it in 33 quarters since. The position peaked at $30.8M in Q1 2015. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.
- QS Investors held 17,743 shares of Elevance Health worth $6.78M as of Q2 2021.
- QS Investors bought 9,139 Elevance Health shares in Q2 2021, an estimated $3.49M.
- Elevance Health made up 0.08% of QS Investors's portfolio in Q2 2021, its #185 holding.
- QS Investors first reported a position in Elevance Health in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Elevance Health position peaked at $30.8M in Q1 2015.
- 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.